Clinical Trial Update: Safety and Efficacy of Bone Marrow Derived MNCs for Treatment of Cells for the Treatment of Hunting Tons Chorea. [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study evaluating the safety and potential efficacy of bone marrow-derived mononuclear cells for Huntington's di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• bone marrow-derived mononuclear cells

Snippet

Sponsor: Chaitanya Hospital, Pune | Conditions: Huntington Disease | Phase 1, Phase 2 | Status: UNKNOWN